Degron Therapeutics vs Poplar Therapeutics
Degron Therapeutics vs Poplar Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Degron Therapeutics is on 62/100 and Poplar Therapeutics on 51/100.
Where each one leads
Degron Therapeutics
- our overall score: 62/100 against 51/100
- domain rating: 25/100 against 4/100
- headcount: 24 against 15
Poplar Therapeutics
- agent readiness: 40/100 against 27/100
- funding raised: $50.0M against $40.0M
At a glance
| Measure | Degron Therapeutics | Poplar Therapeutics |
|---|---|---|
| What it is | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. | Developing a new class of anti-IgE therapy for multiple atopic conditions. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare | Biotechnology, Pharmaceuticals, HealthTech, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2021 |
| Headquarters | San Diego, USA | Boston, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Degron Therapeutics | Poplar Therapeutics |
|---|---|---|
| Employees | 24 | 15 |
| Total funding | $40.0M | $50.0M |
| Latest round | Series A Extension | Series A |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,380 | 1,205 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Degron Therapeutics | Poplar Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 51/100 |
| Traction | Not published | 51/100 |
| Team | 24/100 | 30/100 |
| Search visibility | 57/100 | 25/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Degron Therapeutics | Poplar Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Degron Therapeutics vs Poplar Therapeutics: common questions
Which is better, Degron Therapeutics or Poplar Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Degron Therapeutics and Poplar Therapeutics compare on the numbers?
Degron Therapeutics leads on our overall score (62/100 against 51/100), domain rating (25/100 against 4/100), headcount (24 against 15). Poplar Therapeutics leads on agent readiness (40/100 against 27/100), funding raised ($50.0M against $40.0M).
Read the full Degron Therapeutics review and pricing or the Poplar Therapeutics review and pricing. You can also browse other Degron Therapeutics alternatives we track.